Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Characterization of <i>N</i>-Acetylcysteine-Conjugated PAMAM Dendrimers: Biophysical Evaluation of Their Interactions with Proteins and Drug Delivery Applications.

ACS applied bio materials·2026
Same author

Nose-to-Brain Delivery of Donepezil Hydrochloride via Oleic Acid-Conjugated PAMAM G4 Dendrimers for the Treatment of Alzheimer's-Like Dementia.

Molecular pharmaceutics·2025
Same author

Development and characterization of multifunctional dendrimeric nanoconjugates for delivery of rutin: <i>in vitro</i> characterization for potential neuroprotective application.

Nanomedicine (London, England)·2025
Same author

Multimodal machine learning for deception detection using behavioral and physiological data.

Scientific reports·2025
Same author

Effect of Tween 80 and Pluronic 127 on the stabilization of zein nanocarriers for the delivery of piperine.

Food research international (Ottawa, Ont.)·2024
Same author

Nanoformulations of amphotericin B to resolve challenges in antifungal therapy.

Nanomedicine (London, England)·2024

Related Experiment Video

Updated: Jun 13, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

Dendrimer toxicity: Let's meet the challenge.

Keerti Jain1, Prashant Kesharwani, Umesh Gupta

  • 1Pharmaceutics Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University Sagar (M.P.) 470003 India.

International Journal of Pharmaceutics
|May 4, 2010
PubMed
Summary

Dendrimers offer versatile drug delivery but face toxicity issues due to cationic charges. Surface modifications and biocompatible designs are key to overcoming these limitations for clinical applications.

More Related Videos

Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors
16:19

Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors

Published on: September 10, 2013

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation
14:46

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

Related Experiment Videos

Last Updated: Jun 13, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors
16:19

Synthesis, Cellular Delivery and In vivo Application of Dendrimer-based pH Sensors

Published on: September 10, 2013

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation
14:46

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

Area of Science:

  • Polymer Chemistry
  • Nanomedicine
  • Biotechnology

Background:

  • Dendrimers are highly branched polymers with biomolecule-like properties.
  • Their unique architecture makes them excellent carriers for various drugs, improving solubility and bioavailability.
  • However, their clinical use is limited by inherent toxicity, primarily from cationic surface charges.

Purpose of the Study:

  • To review strategies for overcoming dendrimer toxicity.
  • To highlight methods for enhancing dendrimer biocompatibility for pharmaceutical applications.
  • To emphasize surface engineering approaches for safer dendrimer-based therapeutics.

Main Methods:

  • Review of literature on dendrimer synthesis and modification.
  • Analysis of in vitro and in vivo studies evaluating dendrimer biocompatibility.
  • Examination of surface engineering techniques like PEGylation, acetylation, and charge alteration.

Main Results:

  • Cationic dendrimers interact with cell membranes, causing toxicity (hemolytic, cytotoxic, hematological).
  • Biocompatible dendrimer synthesis involves biodegradable components or metabolic pathway intermediates.
  • Surface modification strategies, including neutralization (PEGylation) or introducing negative charges, effectively mitigate toxicity.

Conclusions:

  • Neutral or negatively charged dendrimers exhibit improved biocompatibility and are suitable for clinical use.
  • Chemical modification of dendrimer surfaces is crucial for overcoming cationic toxicity.
  • Further research into biocompatible dendrimer design is essential for advancing nanomedicine.